https://ecancer.org/en/news/17560-car-t-cell-therapy-for-solid-tumours-may-advance-cancer-treatments
CAR T-cell therapy for solid tumours may advance cancer treatments - ecancer
Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising branches of modern fundamental and clinical oncology.
car t cell therapyfor solid
https://www.royalsurrey.nhs.uk/chemotherapy-consent-forms-for-solid-tumours
Chemotherapy Consent Forms for Solid Tumours | Royal Surrey NHS Foundation Trust
consent formssolid tumourschemotherapy
https://ecancer.org/en/news/18933-ena-2020-inhibitor-of-kras-gene-mutation-shows-promise-in-lung-bowel-and-other-solid-tumours
ENA 2020: Inhibitor of KRAS gene mutation shows promise in lung, bowel and other solid tumours -...
New results from early clinical trials of a drug that targets a cancer-causing mutation in the KRAS gene have shown that it can shrink tumours and is well-to
https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18976966
Cognitive function after chemotherapy in adults with solid tumours
cognitive functionchemotherapyadultssolidtumours
https://christie.openrepository.com/items/fb3a1b0f-9ff4-4b65-bf7d-a2bc989d01ca
Whole-body integral dose and post-radiotherapy lymphocytopaenia in solid tumours
OBJECTIVE: Since modern radiotherapy techniques such as intensity-modulated radiotherapy (IMRT) pivot on a strategy of dose redistribution, it may increase...
whole bodyintegraldose